6.
Zhu X, Li R, Zhu Y, Zhou J, Han X, Tong Y
. Neutrophil/lymphocyte, platelet/lymphocyte, monocyte/lymphocyte ratios and systemic immune-inflammation index in patients with depression. Bratisl Lek Listy. 2023; 124(6):471-474.
DOI: 10.4149/BLL_2023_072.
View
7.
Ferrari C, Pott Godoy M, Tarelli R, Chertoff M, Depino A, Pitossi F
. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol Dis. 2006; 24(1):183-93.
DOI: 10.1016/j.nbd.2006.06.013.
View
8.
Chen J, Zhai E, Yuan Y, Wu K, Xu J, Peng J
. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017; 23(34):6261-6272.
PMC: 5603492.
DOI: 10.3748/wjg.v23.i34.6261.
View
9.
Gonzalez H, Contreras F, Pacheco R
. Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells. J Neuroimmune Pharmacol. 2015; 10(4):561-75.
DOI: 10.1007/s11481-015-9618-9.
View
10.
Alster P, Otto-Slusarczyk D, Kutylowski M, Migda B, Wiercinska-Drapalo A, Jablonska J
. The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot study. Front Immunol. 2024; 15:1458713.
PMC: 11338774.
DOI: 10.3389/fimmu.2024.1458713.
View
11.
Pott Godoy M, Tarelli R, Ferrari C, Sarchi M, Pitossi F
. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain. 2008; 131(Pt 7):1880-94.
PMC: 2442423.
DOI: 10.1093/brain/awn101.
View
12.
Tosu A, Biter H
. Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia. Arch Med Sci Atheroscler Dis. 2021; 6:e152-e157.
PMC: 8525247.
DOI: 10.5114/amsad.2021.109253.
View
13.
Schiess N, Cataldi R, Okun M, Fothergill-Misbah N, Ray Dorsey E, Bloem B
. Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority. JAMA Neurol. 2022; 79(9):929-936.
DOI: 10.1001/jamaneurol.2022.1783.
View
14.
Munoz-Delgado L, Labrador-Espinosa M, Macias-Garcia D, Jesus S, Zamora B, Fernandez-Rodriguez P
. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease. Mov Disord. 2023; 38(5):755-763.
DOI: 10.1002/mds.29369.
View
15.
Pringsheim T, Jette N, Frolkis A, Steeves T
. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29(13):1583-90.
DOI: 10.1002/mds.25945.
View
16.
Guo H, Wan C, Zhu J, Jiang X, Li S
. Association of systemic immune-inflammation index with insulin resistance and prediabetes: a cross-sectional study. Front Endocrinol (Lausanne). 2024; 15:1377792.
PMC: 11188308.
DOI: 10.3389/fendo.2024.1377792.
View
17.
Husain M, Shukla R, Dikshit M, Maheshwari P, Nag D, Srimal R
. Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease. Neurochem Res. 2009; 34(8):1427-32.
DOI: 10.1007/s11064-009-9929-4.
View
18.
Chen S, Xiao J, Cai W, Lu X, Liu C, Dong Y
. Association of the systemic immune-inflammation index with anemia: a population-based study. Front Immunol. 2024; 15:1391573.
PMC: 11116595.
DOI: 10.3389/fimmu.2024.1391573.
View
19.
Liu Z, Fan Q, Wu S, Wan Y, Lei Y
. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson's disease. Lipids Health Dis. 2021; 20(1):35.
PMC: 8054377.
DOI: 10.1186/s12944-021-01462-4.
View
20.
Ferrari C, Tarelli R
. Parkinson's disease and systemic inflammation. Parkinsons Dis. 2011; 2011:436813.
PMC: 3049348.
DOI: 10.4061/2011/436813.
View